Velano Adds to Leadership Team and Advisory Board to Accelerate Adoption of Novel Human-Centered Standard of Care for Inpatient Blood Draws
December 05, 2018 08:00 ET
|
Velano Vascular
SAN FRANCISCO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular continues to aggressively expand in pursuit of its mission to dramatically remake blood...
Interface Biologics Announces New V.P., Business Development
December 04, 2018 08:00 ET
|
Interface Biologics Inc
TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical...
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
December 04, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Nephros to Present at the 11th Annual LD Micro Main Event
December 03, 2018 07:30 ET
|
Nephros, Inc.
Presentation Scheduled for 9:30 AM PT on Tuesday, December 4th SOUTH ORANGE, NJ, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage...
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
November 28, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Global Pharmacovigilance Market to witness a CAGR of 13.4% during 2018-2024
November 28, 2018 02:33 ET
|
Energias Market Research
NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- The Global Pharmacovigilance Market is expected to witness CAGR of 13.45% and is projected to reach USD9,300 million by 2024 from USD3,800 million in...
Interface Biologics Completes Pre-IND Meeting with U.S. FDA on Epidel® Technology for treatment of Posterior Inflammatory Eye Diseases
November 27, 2018 08:00 ET
|
Interface Biologics Inc
TORONTO, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical...
Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference
November 15, 2018 08:00 ET
|
Neuronetics
MALVERN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
PAVmed Reports Third Quarter 2018 Financial Results and Provides Business Update
November 15, 2018 07:30 ET
|
PAVmed Inc.
Conference call to be held on November 15, 2018 at 4:30 p.m. Eastern time NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly...
Globus Medical Reports Third Quarter 2018 Results
November 08, 2018 16:15 ET
|
Globus Medical
AUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended...